Literature DB >> 9276740

Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.

Z Zheng1, R D Cummings, P E Pummill, P W Kincade.   

Abstract

The density, molecular isoform, and posttranslational modifications of CD44 can markedly influence growth and metastatic behavior of tumors. Many CD44 functions, including some involving tumors, have been attributed to its ability to recognize hyaluronan (HA). However, only certain CD44-bearing cells bind soluble or immobilized HA. We now show that CD44 made by wild-type Chinese hamster ovary (CHO-K1) cells and a ligand-binding subclone differ with respect to N-linked glycosylation. While both bear CD44 with highly branched, complex-type glycoforms, CD44 expressed by the wild type was more extensively sialylated. CHO-K1 cells which failed to recognize HA when grown in culture gained this ability when grown as a solid tumor and reverted to a non-HA-binding state when returned to culture. The ability of CHO-K1 cells to recognize HA was also reversibly induced when glucose concentrations in the medium were reduced. Glucose restriction influenced CD44-mediated HA binding by many but not all, of a series of murine tumors. Glucose concentrations and glycosylation inhibitors only partially influenced CD44 receptor function on resting murine B lymphocytes. These observations suggest that glucose levels or other local environmental conditions may markedly influence glycosylation pathways used by some tumor cells, resulting in dramatic alteration of CD44-mediated functions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276740      PMCID: PMC508299          DOI: 10.1172/JCI119635

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  73 in total

1.  Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/versican family.

Authors:  H Yamada; K Watanabe; M Shimonaka; Y Yamaguchi
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

2.  Inhibition of the dolichol pathway of protein glycosylation.

Authors:  R T Schwarz; R Datema
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

3.  Role of cell surface O-linked oligosaccharides in adhesion of HL60 cells to fibronectin: regulation of integrin-dependent cell adhesion by O-linked oligosaccharide elongation.

Authors:  N Kojima; M Saito; S Tsuji
Journal:  Exp Cell Res       Date:  1994-10       Impact factor: 3.905

4.  Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.

Authors:  Y Guo; J Ma; J Wang; X Che; J Narula; M Bigby; M Wu; M S Sy
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

5.  Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan.

Authors:  P A McCourt; B Ek; N Forsberg; S Gustafson
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

6.  Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth.

Authors:  S Katoh; J B McCarthy; P W Kincade
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

7.  Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response.

Authors:  J Lesley; N Howes; A Perschl; R Hyman
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

8.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons.

Authors:  S Tsukita; K Oishi; N Sato; J Sagara; A Kawai; S Tsukita
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

9.  Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.

Authors:  E Puré; R L Camp; D Peritt; R A Panettieri; A L Lazaar; S Nayak
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

Authors:  A Bartolazzi; R Peach; A Aruffo; I Stamenkovic
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  6 in total

1.  Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes.

Authors:  Marko Salmi; Craig Stolen; Pekka Jousilahti; Gennady G Yegutkin; Päivi Tapanainen; Tuula Janatuinen; Mikael Knip; Sirpa Jalkanen; Veikko Salomaa
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  CD44 expression and hyaluronic acid binding of malignant glioma cells.

Authors:  M M Knüpfer; H Poppenborg; M Hotfilder; K Kühnel; J E Wolff; M Domula
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells.

Authors:  Megan E Cavet; Elaine M Smolock; Oktay H Ozturk; Cameron World; Jinjiang Pang; Atsushi Konishi; Bradford C Berk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

4.  N-Glycosylation can selectively block or foster different receptor-ligand binding modes.

Authors:  Joni Vuorio; Jana Škerlová; Milan Fábry; Václav Veverka; Ilpo Vattulainen; Pavlína Řezáčová; Hector Martinez-Seara
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

Review 5.  CD44 Glycosylation as a Therapeutic Target in Oncology.

Authors:  Chengcheng Liao; Qian Wang; Jiaxing An; Jie Chen; Xiaolan Li; Qian Long; Linlin Xiao; Xiaoyan Guan; Jianguo Liu
Journal:  Front Oncol       Date:  2022-07-21       Impact factor: 5.738

6.  Cellular O-Glycome Reporter/Amplification to explore O-glycans of living cells.

Authors:  Matthew R Kudelka; Aristotelis Antonopoulos; Yingchun Wang; Duc M Duong; Xuezheng Song; Nicholas T Seyfried; Anne Dell; Stuart M Haslam; Richard D Cummings; Tongzhong Ju
Journal:  Nat Methods       Date:  2015-11-30       Impact factor: 28.547

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.